The long term goals of this proposal are to elucidate the functions of the short chain and medium chain carnitine acyltransferases and acylcarnitines that occur in mammalian systems and to characterize the biochemical processes involved.
The specific aims are: 1) to characterize the purified soluble carnitine octanyltransferase and acetyltransferase mouse liver peroxisomes, 2) to determine the basis for the kinetic and functional differences of the two forms of carnitine palmityltransferase associated with the inner mitochondrial membrane using purified COT/CPT from beef heart mitochondria, 3) to continue characterizing the changes in short chain acylcarnitines which occur in biological tissues subjected to various physiological states, 4) to determine the effect of carnitine on specific aliphatic acylCoAs and the effect of carnitine on the CoASH/acylCoA ratio in the matrix of isolated mitochondria, and 5) to characterize the metabolic fate acetylcarnitine. These studies should provide a better understanding of the metabolic abnormalities which occur as a consequence of carnitine deficiency in humans. Since the major metabolic fuels (glucose, fatty acids, and some amino acids, i.e, branched chain ones and glutamate) all have terminal oxidation steps in the matrix of mitochondria which require CoASH and all have key enzymes effected or regulated by the CoASH/acylCoA ratio, low levels of carnitine should produce a diversity of metabolic profiles depending on the enzyme affected and fuel sources available. The investigations with beef heart COT/CPT should provide new information about the mechanism of the selection of acyl residues oxidized by mitochondria when mixtures of acylCoA derivatives are present. The studies with the purified peroxisomal carnitine acetyl transferase and carnitine octanyltransferase from mouse liver could provide insight into the function of these enzymes in vivo. The studies with radioactive acetylcarnitine in mice should provide direct evidence concerning the metabolic fate of the compound.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM018427-10
Application #
3151141
Study Section
Biochemistry Study Section (BIO)
Project Start
1978-05-01
Project End
1987-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Michigan State University
Department
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Fiol, C J; Bieber, L L (1988) Effects of octylglucoside and triton X-100 on the kinetics and specificity of carnitine palmitoyltransferase. Lipids 23:120-5
Healy, M J; Kerner, J; Bieber, L L (1988) Enzymes of carnitine acylation. Is overt carnitine palmitoyltransferase of liver peroxisomal carnitine octanoyltransferase? Biochem J 249:231-7
Lysiak, W; Lilly, K; DiLisa, F et al. (1988) Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263:1151-6
Fiol, C J; Kerner, J; Bieber, L L (1987) Effect of malonyl-CoA on the kinetics and substrate cooperativity of membrane-bound carnitine palmitoyltransferase of rat heart mitochondria. Biochim Biophys Acta 916:482-92
Melegh, B; Kerner, J; Bieber, L L (1987) Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol 36:3405-9
Farrell, S; Vogel, J; Bieber, L L (1986) Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta 876:175-7
Bieber, L L; Fiol, C J (1986) Characterization and properties of carnitine acyltransferases. Biochem Soc Trans 14:674-6
Lysiak, W; Toth, P P; Suelter, C H et al. (1986) Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria. J Biol Chem 261:13698-703
Bieber, L L; Fiol, C J (1985) Fatty acid and ketone metabolism. Circulation 72:IV9-12
Valkner, K; Ely, S; Kerner, J et al. (1985) Effect of hypoxia on pig heart short-chain acylcarnitines. Comp Biochem Physiol A Comp Physiol 80:123-7

Showing the most recent 10 out of 11 publications